The association of histopathologic features after neoadjuvant chemo-immunotherapy with clinical outcome: Sub-analyses from the randomized double-blinded, placebo-controlled, Phase III IMagyn050/GOG3015/ENGOT-ov39 study

CONCLUSIONS: Detailed histologic assessment of ICS specimens appear to identify characteristics, such as inflammation and residual tumor, that may provide insight to certain clinical outcomes. Future work potentially leveraging emerging tools may provide further insight into outcomes.PMID:38554625 | DOI:10.1016/j.ygyno.2024.03.022

Source: Gynecologic Oncology - March 30, 2024 Category: Cancer & Oncology Authors: Paulette Mhawech-Fauceglia Denis McCarthy Akiko Tonooka Giovanni Scambia Yolanda Garcia Pavel Dundr Anne M Mills Kathleen Moore Sakiko Sanada Leslie Bradford Giulia Carlo Stella Michael Bookman Sudarshan K Sharma Frederic Selle Luciana Molinero Yvette He Source Type: research